cloudfront

Report Detail



Medical IndustryUnited States Gene Therapy Sales Market Report 2021

  • RnM748357
  • |
  • 13 March, 2017
  • |
  • Global
  • |
  • 84 pages
  • |
  • QYResearch
  • |
  • Medical Industry

United States Gene Therapy Sales Market Report 2021

Table of Contents

    1 Gene Therapy Overview 1

    • 1.1 Product Overview and Scope of Gene Therapy 1
    • 1.2 How does Gene Therapy work 1
    • 1.3 Classification of Gene Therapy 3
    • 1.4 Applications of Gene Therapy 6
    • 1.5 USA Market Size (Value and Volume) of Gene Therapy (2011-2021) 7
      • 1.5.1 USA Gene Therapy Investment (2011-2021) 7
      • 1.5.2 USA Gene Therapy Investment and Growth Rate (2011-2021) 8

    2 USA Gene Therapy Competition by Manufacturers 10

    • 2.1 USA Gene Therapy Investment Analysis of Key Manufacturers (2015 and 2016) 10
    • 2.2 USA Gene Therapy Investment Market Share of Key Manufacturers (2015 and 2016) 11

    3 USA Gene Therapy by Type 13

    • 3.1 USA Gene Therapy Investment Analysis by Type (2011-2021) 13
    • 3.2 USA Gene Therapy Investment and Growth Rate by Type (2011-2021) 15

    4 USA Gene Therapy by Application 17

    • 4.1 USA Gene Therapy Investment Analysis by Application (2011-2021) 17
    • 4.2 USA Gene Therapy Investment and Growth Rate by Application (2011-2021) 19

    5 USA Gene Therapy Manufacturers Analysis 24

    • 5.1 Bluebird Bio 24
      • 5.1.1 Company Basic Information, Manufacturing Base and Competitors 24
      • 5.1.2 Gene Therapy Product Type and Technology 25
      • 5.1.3 Gene Therapy Sales, Revenue, Price of Bluebird Bio (2015 and 2016) 27
    • 5.2 Sangamo 27
      • 5.2.1 Company Basic Information, Manufacturing Base and Competitors 27
      • 5.2.2 Gene Therapy Product Type and Technology 29
      • 5.2.3 Gene Therapy Sales, Revenue, Price of Sangamo (2015 and 2016) 31
    • 5.3 Spark Therapeutics 31
      • 5.3.1 Company Basic Information, Manufacturing Base and Competitors 31
      • 5.3.2 Gene Therapy Product Type and Technology 32
      • 5.3.3 Gene Therapy Sales, Revenue, Price of Spark Therapeutics (2015 and 2016) 35
    • 5.4 Dimension Therapeutics 36
      • 5.4.1 Company Basic Information, Manufacturing Base and Competitors 36
      • 5.4.2 Gene Therapy Product Type and Technology 37
      • 5.4.3 Gene Therapy Sales, Revenue, Price of Dimension Therapeutics (2015 and 2016) 38
    • 5.5 Avalanche Bio 38
      • 5.5.1 Company Basic Information, Manufacturing Base and Competitors 38
      • 5.5.2 Gene Therapy Product Type and Technology 40
      • 5.5.3 Gene Therapy Sales, Revenue, Price of Avalanche Bio (2015 and 2016) 40
    • 5.6 Celladon 41
      • 5.6.1 Company Profile 41
      • 5.6.2 Gene Technology 42
      • 5.6.3 Investment, Market Share and Growth Rate 42
    • 5.7 Vical 43
      • 5.7.1 Company Profile 43
      • 5.7.2 Gene Technology 44
      • 5.7.3 Investment, Market Share and Growth Rate 46
    • 5.8 Advantagene 46
      • 5.8.1 Company Profile 46
      • 5.8.2 Gene Technology 48
      • 5.8.3 Investment, Market Share and Growth Rate 51

    6 Gene Therapy Technology and Development Trend 52

    • 6.1 Gene Therapy Technology Analysis 52
      • 6.1.1 Gene Augmentation Therapy 56
      • 6.1.2 Gene Inhibition Therapy 58
      • 6.1.3 Killing of Specific Cells 60
    • 6.2 Gene Therapy Technology Development Trend 61

    7 Global Gene Therapy Trials Analysis 63

    • 7.1 Global Gene Therapy Trials Analysis by Region 63
    • 7.2 Global Gene Therapy Trials Analysis by Country 64
    • 7.3 Global Gene Therapy Trials Analysis by Indications 66
    • 7.4 Global Gene Therapy Trials Analysis by Gene Type 68
    • 7.5 Global Gene Therapy Trials Analysis by Phases 69
    • 7.6 Global Number of Gene Therapy Trials Approved 1989-2016.02 71

    8 Research Findings and Conclusion 72

      Disclosure Section 73

        Research Methodology 73

          Data Source 75

            China Disclaimer 75

            This report studies sales (consumption) of Gene Therapy in USA market player, covering
            Bluebird Bio
            Sangamo
            Spark Therapeutics
            Dimension Therapeutics
            Avalanche Bio
            Celladon
            Vical
            Advantagene



            REPORT YOU MIGHT BE INTERESTED

            Purchase this Report

            $3,800.00
            $4,940.00
            2,551.70
            3,317.21
            3,496.76
            4,545.79
            460,332.00
            598,431.60
            251,990.92
            327,588.20
            Add To Cart Credit card Logo

            Related Reports


            Reason to Buy

            Request for Sample of this report